Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study.
Pascoe MM, Wollet AR, De La Cruz Minyety J, Vera E, Miller H, Celiku O, Leeper H, Fernandez K, Reyes J, Young D Jr, Acquaye-Mallory A, Adegbesan K, Boris L, Burton E, Chambers CP, Choi A, Grajkowska E, Kunst T, Levine J, Panzer M, Penas-Prado M, Pillai V, Polskin L, Wu J, Gilbert MR, Mendoza T, King AL, Shuboni-Mulligan D, Armstrong TS. Pascoe MM, et al. Among authors: vera e. Neurooncol Pract. 2024 May 24;11(5):640-651. doi: 10.1093/nop/npae048. eCollection 2024 Oct. Neurooncol Pract. 2024. PMID: 39279778 Free article.
Sleep-wake disturbance in patients with brain tumors.
Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM. Armstrong TS, et al. Among authors: vera e. Neuro Oncol. 2017 Mar 1;19(3):323-335. doi: 10.1093/neuonc/now119. Neuro Oncol. 2017. PMID: 27286798 Free PMC article. Review.
The prevalence of altered body image in patients with primary brain tumors: an understudied population.
Rowe L, Vera E, Acquaye A, Crandon S, Shah V, Bryla C, Wu J, Wall K, Siegel C, Reyes J, Penas-Prado M, Leggiero N, Cordova C, Burton E, Antony R, Boris L, Aboud O, Vyas Y, Mathen P, Gilbert M, Camphausen K, Mendoza T, Armstrong T. Rowe L, et al. Among authors: vera e. J Neurooncol. 2020 Apr;147(2):397-404. doi: 10.1007/s11060-020-03433-8. Epub 2020 Feb 24. J Neurooncol. 2020. PMID: 32096067 Free PMC article.
Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study.
Rogers JL, Vera E, Acquaye A, Briceno N, Jammula V, King AL, Leeper H, Quezado MM, Gonzalez Alarcon J, Boris L, Burton E, Celiku O, Choi A, Christ A, Crandon S, Grajkowska E, Leggiero N, Lollo N, Penas-Prado M, Reyes J, Siegel C, Theeler BJ, Timmer M, Wall K, Wu J, Aldape K, Gilbert MR, Armstrong TS. Rogers JL, et al. Among authors: vera e. Neurooncol Pract. 2021 Apr 10;8(4):460-474. doi: 10.1093/nop/npab022. eCollection 2021 Aug. Neurooncol Pract. 2021. PMID: 34277024 Free PMC article.
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.
Jammula V, Rogers JL, Vera E, Christ A, Leeper HE, Acquaye A, Briceno N, Choi A, Grajkowska E, Levine JE, Lindsley M, Reyes J, Roche KN, Timmer M, Boris L, Burton E, Lollo N, Panzer M, Smith-Cohn MA, Penas-Prado M, Pillai V, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. Jammula V, et al. Among authors: vera e. Neurooncol Pract. 2022 May 14;9(5):429-440. doi: 10.1093/nop/npac038. eCollection 2022 Oct. Neurooncol Pract. 2022. PMID: 36124322 Free PMC article.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye AA, Adegbesan K, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill M, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: vera e. Res Sq [Preprint]. 2023 Jan 31:rs.3.rs-2522094. doi: 10.21203/rs.3.rs-2522094/v1. Res Sq. 2023. Update in: J Neurooncol. 2023 Mar;162(1):137-145. doi: 10.1007/s11060-023-04271-0. PMID: 36789426 Free PMC article. Updated. Preprint.
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering.
Bergsneider BH, Vera E, Gal O, Christ A, King AL, Acquaye A, Choi A, Leeper HE, Mendoza T, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai T, Polskin L, Wu J, Gilbert MR, Armstrong TS, Celiku O. Bergsneider BH, et al. Among authors: vera e. Neurooncol Adv. 2022 Dec 26;5(1):vdac188. doi: 10.1093/noajnl/vdac188. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36820236 Free PMC article.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
King AL, Roche KN, Leeper HE, Vera E, Mendoza T, Mentges K, Acquaye-Mallory AA, Adegbesan KA, Boris L, Burton E, Choi A, Grajkowska E, Kunst T, Levine J, Lollo N, Miller H, Panzer M, Penas-Prado M, Pillai V, Polskin L, Reyes J, Sahebjam S, Stockdill ML, Theeler BJ, Wu J, Gilbert MR, Armstrong TS. King AL, et al. Among authors: vera e. J Neurooncol. 2023 Mar;162(1):137-145. doi: 10.1007/s11060-023-04271-0. Epub 2023 Mar 8. J Neurooncol. 2023. PMID: 36884201 Free PMC article. Clinical Trial.
206 results